SUPPRESSION OF 24-HOUR CHOLECYSTOKININ SECRETION BY ORAL-CONTRACEPTIVES

被引：14
|
作者：
KARLSSON, R
LINDEN, A
VONSCHOULTZ, B
机构：
[1] KAROLINSKA HOSP,DEPT OBSTET & GYNECOL,S-10401 STOCKHOLM 60,SWEDEN
[2] UMEA UNIV,DEPT FAMILY MED,S-90187 UMEA,SWEDEN
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1992年 / 167卷 / 01期
关键词：
ORAL CONTRACEPTIVES; CHOLECYSTOKININ; SECRETORY PROFILE;
D O I：
10.1016/S0002-9378(11)91626-3
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Weight gain is a common side effect during oral contraceptive use. The secretion of the satiety hormone cholecystokinin was recorded for 24 hours in women before and during treatment with oral contraceptives. During treatment serum profiles of cholecystokinin were clearly suppressed, which might be related to increased appetite and weight gain.
引用
收藏
页码：58 / 59
页数：2
相关论文
共 50 条
  • [21] FACTOR-VII ACTIVATION AND ORAL-CONTRACEPTIVES
    PLUBUREAU, G
    SCARABIN, PY
    BARA, L
    MALMEJAC, A
    GUIZE, L
    SAMAMA, M
    THROMBOSIS RESEARCH, 1993, 70 (03) : 275 - 280
  • [22] STRESS, SEROTONERGIC FUNCTION, AND MOOD IN USERS OF ORAL-CONTRACEPTIVES
    TUITEN, A
    PANHUYSEN, G
    KOPPESCHAAR, H
    FEKKES, D
    PIJL, H
    FROLICH, M
    KRABBE, P
    EVERAERD, W
    PSYCHONEUROENDOCRINOLOGY, 1995, 20 (03) : 323 - 334
  • [23] INTERACTIONS BETWEEN CLINICALLY USED DRUGS AND ORAL-CONTRACEPTIVES
    BOLT, HM
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 35 - 38
  • [24] ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLISM - A QUANTITATIVE DISCUSSION OF THE UNCERTAINTIES
    KOSTER, T
    SMALL, RA
    ROSENDAAL, FR
    HELMERHORST, FM
    JOURNAL OF INTERNAL MEDICINE, 1995, 238 (01) : 31 - 37
  • [25] THE ESTROGENIC ACTIVITY OF SYNTHETIC PROGESTINS USED IN ORAL-CONTRACEPTIVES
    JORDAN, VC
    JENG, MH
    CATHERINO, WH
    PARKER, CJ
    CANCER, 1993, 71 (04) : 1501 - 1505
  • [26] PREVIOUS USE OF ORAL-CONTRACEPTIVES AND SPONTANEOUS-ABORTION
    SACKOFF, J
    KLINE, J
    SUSSER, M
    EPIDEMIOLOGY, 1994, 5 (04) : 422 - 428
  • [27] ASSESSING THE RISK OF OVULATION IN INTERACTION STUDIES OF DRUGS AND ORAL-CONTRACEPTIVES
    DELAREY, N
    SCHALL, R
    LUUS, HG
    MEYER, BH
    MULLER, FO
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1993, 31 (09) : 435 - 439
  • [28] INFLUENCE OF ORAL-CONTRACEPTIVES ON COAGULATION TESTS IN NATIVE BLOOD AND PLASMA
    KUNZ, F
    PECHLANER, C
    TABARELLI, M
    SOLDER, E
    ZWIERZINA, WD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) : 417 - 420
  • [29] ORAL-CONTRACEPTIVES, INSULIN RESISTANCE AND ISCHEMIC VASCULAR-DISEASE
    ESCHWEGE, E
    FONTBONNE, A
    SIMON, D
    THIBULT, N
    BALKAU, B
    SAINTPAUL, M
    GARNIER, P
    SENAN, C
    PAPOZ, L
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1990, 31 (03) : 263 - 269
  • [30] SUB-50 ORAL-CONTRACEPTIVES AFFECT FOLATE KINETICS
    STEEGERSTHEUNISSEN, RPM
    VANROSSUM, JM
    STEEGERS, EAP
    THOMAS, CMG
    ESKES, TKAB
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1993, 36 (04) : 230 - 233
12345